Aprea Therapeutics Inc (APRE) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.88
• Market Cap: $5.59M
• EPS: $-2.12
• 52-Week High: $2.79
• 52-Week Low: $0.55

Market Sentiment

Aprea Therapeutics Inc currently has a Bullish sentiment score of 0.32.

About Aprea Therapeutics Inc

Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Boston, focused on advancing innovative cancer therapies by targeting the reactivation of the mutant p53 tumor suppressor protein, which plays a critical role in tumor suppression. With a diverse pipeline aimed at multiple cancer indications, Aprea is poised to make a substantial impact on the oncology market. The company’s unique therapeutic approach, combined with a steadfast dedication to enhancing pati...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Aprea Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does APRE pay dividends?

Aprea Therapeutics Inc (APRE) does not currently pay a regular dividend.

What is APRE's market cap?

Aprea Therapeutics Inc (APRE) has a market capitalization of $5.59M with a current stock price of $0.88.